Financhill
Sell
29

ACM Quote, Financials, Valuation and Earnings

Last price:
$97.36
Seasonality move :
1.64%
Day range:
$96.78 - $97.98
52-week range:
$85.00 - $135.52
Dividend yield:
1.07%
P/E ratio:
21.46x
P/S ratio:
0.81x
P/B ratio:
5.16x
Volume:
549.8K
Avg. volume:
1.7M
1-year change:
-10.07%
Market cap:
$12.9B
Revenue:
$16.1B
EPS (TTM):
$4.54

ACM Analysts' Consensus Rating

The 11 analysts providing 12-month price projections for AECOM shares anticipate an average target of $138.08, ranging from a low estimate of $100.00 to a high estimate of $155.00. This average target implies a growth of 41.64% compared to the current stock price of $97.49.

Consensus Price Target

$138.08

Highest Price Target

$155.00

Lowest Price Target

$100.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 8 8 8

Hold 2 2 3

Sell 0 0 0
Consensus Buy Buy Buy

ACM Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 26

Travere Therapeutics, Inc. [TVTX] is down 1.54% over the past day.

Buy
64
ZCSH alert for Dec 26

Grayscale Zcash Trust (ZEC) [ZCSH] is down 3.73% over the past day.

Buy
60
AAOI alert for Dec 26

Applied Optoelectronics, Inc. [AAOI] is down 9.39% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock